NewsBenzingaTruist Securities维持对Genmab的“买入”评级，将目标价上调至45美元 Truist Securities维持对Genmab的“买入”评级，将目标价上调至45美元 Benzinga 2026.10.07 16:45 (GMT+0) Open on Benzinga Other news Stocks Supported by a Rebound in Chipmakers and AI-Infrastructure Companies Taiwan’s President Called on Micron and Workers to Negotiate Ahead of a Possible Strike. Here’s What to Know. 3 Token Unlocks to Watch in the Fourth Week of October 2026 Rocket Lab's Biggest Technological Advantage Is Fast Becoming Its Biggest Problem Why Is IREN Stock Surging Monday? Venture Global Stock Just Secured a Data Center Win. How to Play It Here.
Taiwan’s President Called on Micron and Workers to Negotiate Ahead of a Possible Strike. Here’s What to Know.
